Nerve Growth Factor Expression and Release in Allergic Inflammatory Disease of the Upper Airways
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
It is well known that allergic airways disease is characterized by inflammation and hyperresponsiveness, but the link between these two conditions has not been elucidated. We have previously shown that in allergic rhinitis, hyperresponsiveness is attributable to increased neural reactivity. We thus hypothesized that nerve growth factor (NGF), which is expressed by inflammatory cells and effects changes that lead to increased neural responsiveness, could be a pivotal mediator in this disease. Using reverse transcription-polymerase chain reaction (RT-PCR), Western immunoblotting, and ELISA to evaluate NGF expression and release, we found that subjects with allergic rhinitis have significantly decreased NGF mRNA in superficial nasal scrapings and significantly higher baseline concentrations of NGF protein in nasal lavage fluids, compared with control subjects. Nasal provocation with allergen significantly increased NGF protein in nasal lavage fluids of subjects with allergic rhinitis, but not of control subjects. The concentrations of NGF protein in nasal lavage fluids were not affected by provocation with the vehicle for allergen or with histamine. These data provide the first evidence of a steady state of dysregulation in mucosal NGF expression and release in allergic rhinitis, and support a role of this neurotrophin in the pathophysiology of allergic inflammatory disease of the human airways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions
Bienenstock, J., Tomioka, M., Matsuda, H., Stead, R. H., Quinonez, G., Simon, G. T., Coughlin, M. D., & Denburg, J. A. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234197 · Cited by 193
Self-citation
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
“Neurotrophins, such as the nerve growth factor (806), are prime candidates as mediators of neural hyperresponsiveness (807).”
BackgroundSelf-citationBousquet, J., Anto, J. M., Bachert, C., Baiardini, I., Bosnic-Anticevich, S., Walter Canonica, G., Melén, E., Palomares, O., Scadding, G. K., Togias, A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00227-0 · Cited by 942
Self-citationMicera, A., Vigneti, E., Pickholtz, D., Reich, R., Pappo, O., Bonini, S., Maquart, F. X., Aloe, L., & Levi-Schaffer, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101130898 · Cited by 243
The mast cell and allergic diseases: role in pathogenesis and implications for therapy
Brown, J. M., Wilson, T. M., & Metcalfe, D. D. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02886.x · Cited by 212
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper
Bousquet, J., Fokkens, W., Burney, P., Durham, S. R., Bachert, C., Akdis, C. A., Canonica, G. W., Dahlen, S. ‐., Zuberbier, T., Bieber, T., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01715.x · Cited by 178
“Neurotrophins, such as the nerve growth factor (122), are prime candidates for mediators of neural hyperresponsiveness.”
Background
Metadata
- Authors
- SANICO, A. M., STANISZ, A. M., GLEESON, T. D., BORA, S., PROUD, D., BIENENSTOCK, J., KOLIATSOS, V. E., & TOGIAS, A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05-01
- Volume
- 161
- Issue
- 5
- Pages
- 1631-1635
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1997155157
- Cited by
- 166
- References
- 1
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.